D
Lucid Diagnostics Inc. LUCD
$1.26 $0.086.78% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 59.66% -153.56% -6.57% 12.93% 3.30%
Total Depreciation and Amortization -3.06% -55.89% -64.71% -65.60% -63.82%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -565.48% 1,775.09% 16.78% -50.69% 6.71%
Change in Net Operating Assets 62.96% 59.18% 574.63% -127.63% -171.44%
Cash from Operations 8.13% 1.17% 1.08% -15.88% -65.52%
Capital Expenditure -- -151.35% -48.00% 100.00% 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -151.35% -48.00% -2,400.00% 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 4,123.53% -- -65.82% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -100.00% -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 41.49% -16.65% 259.98% -65.82% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 3,797.35% -50.96% 252.68% -22.43% 102.17%